• Billboard-Tom-2013
    Billboard-Tom-2013
  • ClinicalTrialsParticipant-Carol
    ClinicalTrialsParticipant-Carol
  • 0007
    0007
  • 322x
    322x
  • 308x
    308x
  • 0221x
    0221x
  • 0095x
    0095x
  • 0090x
    0090x
  • 0029x
    0029x
  • 0001x
    0001x
  • 0026x
    0026x

The Nebraska Cancer Research Center

Since 1984, The Nebraska Cancer Research Center has been a leader in cancer research, providing local access to National Cancer Institute-sponsored cancer clinical trials. Over 1,900 volunteers have participated in treatment, prevention and control trials through NCRC, helping to identify more effective cancer treatments and improve the quality of life of cancer patients.

CONGRATS to Sandi Hansen - Winner of the raffle for the 2013 Mercedes Benz C250 Sport!!

New Clinical Trials

View all clinical trials available at NCRC.

GOG 3004: A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer following First Line Platinum Based Chemotherapy.

S1400: Squamous Cell Lung Cancer - Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung Cancer.

E1912: Chronic Lymphocytic Leukemia - A Randomized Phase III Study of Ibrutinib (PCI-32765)-based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)

R0920: Head and Neck Cancer - A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer